2024 Agenda
The forum will highlight recent advances, current trends, and innovations that will shape the future of ophthalmology.
Thursday, June 20, 2024 – INVITE ONLY EVENTS
3:00 – 4:30 pm PST
EXPERIENCE
Tier 1 Sponsor Advisory Board Opportunity (Sold Out)
4:30 – 5:30 pm PST
EXPERIENCE
OWL Socal Chapter Meeting
4:30 – 5:30 pm PST
EXPERIENCE
Partnership Pursuit: Physician & Entrepreneur Reception
This is a unique opportunity for you to meet these innovative entrepreneurs and determine if there is a mutually beneficial fit and interest. These companies will be within the medical industry, not necessarily ophthalmic specific, and provide a good opportunity to contribute your diverse perspective.
5:30 – 7:00 pm PST
EXPERIENCE
Welcome Reception
Friday, June 21, 2024
6:30 – 8:00 am PST
EXPERIENCE
Tier 1 Sponsor Advisory Board Opportunity (Sold Out)
7:00 – 8:00 am PST
EXPERIENCE
Registration, Exhibits & Continental Breakfast
Network with colleagues! You can also set appointments within our virtual platform or take part in a networking session catered to your interests.
8:00 – 8:10 am PST
OPENING
Opening Comments
Octane CEO, Bill Carpou will reflect on the impact of ophthalmology in Southern California and beyond.
Bill Carpou, CEO, Octane
8:10 – 8:35 am PST
State of the Ophthalmic Industry Report
Hear from an industry-leading expert on eyecare’s current and future investment trends and growth opportunities.
Sergio Rossi, Managing Director & Partner, Boston Consulting Group
8:35 – 9:05 am PST
KEYNOTE
Keynote Interview
Euan Thomson, PhD, President of Ophthalmic Devices and Head of Digital Business Unit, Carl Zeiss Meditec Inc.
Jim Mazzo, Executive Chairman, Neurotech, Co-Founder, Octane
9:05 – 9:35 am PST
PANEL
Innovations in the Posterior Segment
Leading Posterior Segment surgeons will present their favorite new and upcoming technologies. An interactive panel discussion will follow the presentations.
Bob Avery, MD, California Retina Consultants
Doug Faunce, Executive Director, External Disease, AbbVie
Aaron Osborne, Executive Director Ophthalmology, USMA, Genentech, Inc.
9:35 – 10:05 am PST
PANEL
Refractive Panel, Anterior Segment, Cornea
Leading Anterior Segment surgeons will present the new and future technologies they are most excited about for their practices. An interactive panel discussion will follow the presentations.
Ehsan Sadri, MD, FACS, CEO and Founder, Visionary Eye Institute (Moderator)
Alex Lopez, Chief Commercial Officer, Ace Vision Group
Lisa Nijm, MD, JD, Founder and Medical Director, Warrenville Eyecare and LASIK
Adam Szaronos, President & CEO, Trukera Medical
10:05 – 10:35 am PST
PANEL
Innovations and Applications in Genetic Engineering and Cell Transplantation
The future of medicine is here! This cutting-edge panel will feature leading experts in genetic engineering and cell transportation. The panelists will discuss which technologies are at the forefront and where the industry is headed in this exciting space.
Baruch Kuppermann, MD, PhD, Steinert Endowed Professor, Chair, Department of Ophthalmology, Director, Gavin Herbert Eye Institute, University of California, Irvine (Moderator)
Greg Kunst, Chief Executive Officer, Aurion Biotech
Jeffrey L. Goldberg, MD, PhD, Co-founder and Director, Board of Managers, Emmecell
John Pollack, MD, Chief Medical Officer, jCyte, Inc.
Richard Small, Chief Executive Officer & Board of Directors, Neurotech Pharmaceuticals, Inc.
10:35 – 11:05 am PST
EXPERIENCE
Break: Networking, Exhibits & Coffee
11:05 am – 11:25 pm PST
TARSUS FIRESIDE CHAT
Aziz Mottiwala, Chief Commercial Officer, Tarsus Pharmaceuticals, Inc.
John Hovanesian, MD, FACS, Private Practice, Harvard Eye Associates, Laguna Hills, CA Clinical Faculty, UCLA Jules Stein Eye Institute, Los Angeles, CA
11:25 – 12:00 pm PST
PANEL
Private Equity: The Good, The Bad, The Ugly
Join our industry experts in hearing the latest information on what is happening with Private Equity. Learn about how it works, the existing challenges, and what we will see in
Cynthia Matossian, MD, FACS, President, CM Associates, LLC
Farrel “Toby” Tyson, MD, FACS, Tyson Eye
Denise M. Visco, MD, MBA, Medical Director, Eyes of York
12:00 – 12:20 pm PST
EXPERIENCE
Ramin Valian, Vice President-Eye Care and Pipeline Commercialization Strategy, AbbVie
Nicole Fram, MD, Managing Partner, Advanced Vision Care
12:20 – 12:30 pm PST
EXPERIENCE
The Roger Steinert, MD Legacy Award Presented by The Gavin Herbert Eye Institute
Baruch Kuppermann, MD, PhD, Steinert Endowed Professor, Chair, Department of Ophthalmology, Director, Gavin Herbert Eye Institute, University of California, Irvine
12:30 – 1:10 pm PST
EXPERIENCE
Lunch and Networking
1:10 – 2:30 pm PST
EXPERIENCE
Capital & Growth Company Presentations
Judges:
Mayssa Attar, PhD, Head of Pharmaceuticals R&D, Bausch & Lomb
Tara Capalbo, General Manager, Ocular Surface Disease and Glaucoma
2:30 – 3:00 pm PST
PANEL
The Investment Landscape
Andrew Stewart, President, Global Ophthalmic Pharmaceuticals, Bausch & Lomb (moderator)
Jeffry Weinhuff, Founder & Managing Partner, Visionary Ventures
3:00 – 3:15 pm PST
EXPERIENCE
Break: Exhibits & Networking
3:15 – 3:45 pm PST
PANEL
The Changing Ophthalmic Practice
Industry and physician experts will discuss the latest in aesthetics, cash pay technologies, practice growth opportunities, and upcoming elective trends in eye care.
Mark Kontos, MD, Empire Eye (RxSight, Inc.)
Marc Odrich, CMO, Lenz Therapeutics
Paul Smith, President & COO, Orasis Pharmaceuticals
3:45 – 4:15 pm PST
PRO/CON DEBATE
Join us, as top industry physicians debate the hottest topics in eye care!
ICL/Refractive
Patient Profile: What technology would you use?
Premium IOL’s/Dry Eye Protocols
4:15 – 4:45 pm PST
PRESENTATION
The Modern Ophthalmology Practice
AI is already changing our everyday lives. This session will feature a series of presentations by leading experts focusing on advancing AI, what it means to our industry, and its impact on surgical practices and patients.
Peter Menzisuo, Company Group Chairman, Johnson & Johnson Vision (Moderator)
4:45 – 5:15 pm PST
PANEL
The Great Debate: Glaucoma Drug Delivery Vs Drainage Devices
Leading industry and surgeon glaucoma experts will present some of the leading innovations in glaucoma. Join us to discuss recent technology advancements and the changing reimbursement environment.
Shawn O’Neil, Chief Commercial Officer, ViaLase Inc.
Mitchell Shultz, MD, Medical Director, Shultz Chang Vision, Co-Founder and Chief Medical Officer, Alchemy Vision
Kuldev Singh, MD, MPH, Professor of Ophthalmology and Director of the Glaucoma Service, Stanford University
5:15 – 5:20 pm PST
EXPERIENCE
Closing Comments
Bill Carpou, CEO, Octane
5:20 – 7:30 pm PST
Closing Reception
Saturday, June 22, 2024
6:45 – 11:45 am PST
EXPERIENCE
Tier 1 Advisory Board Meetings
6:45 – 8:15 am
8:30 – 10:00 am (sold out)
10:15 – 11:45 am
OC Innovation Week: Opening Reception
UCI Beall Applied Innovation 5270 California Ave # 100, Irvine, CAJoin us for the grand kickoff of OC Innovation Week at our Opening Reception, where excitement and innovation converge.
Fast Pitch
The Cove at UCI Applied Innovation 5270 California Ave, Irvine, CA, United StatesFast Pitch is a unique opportunity for Orange County's tech innovators to showcase their groundbreaking ideas. Participants present their pitches to a distinguished panel of judges, potential partners, and investors.